Coronavirus Pandemic and the Future

Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2

Inbunden, Engelska, 2022

Av Michael D Waters, Alok Dhawan, Tim Marrs, Diana Anderson, Stafford Warren, Claude L Hughes, USA) Waters, Michael D (Integrated Laboratory Systems (ILS) Inc., India) Dhawan, Alok (Centre of BioMedical Research, SGPGIMS Campus, UK) Marrs, Tim (Edentox Associates, UK) Anderson, Diana (University of Bradford, USA) Warren, Stafford (Chesapeake Cardiac Care, USA) Hughes, Claude L (IQVIA, Michael D. Waters

2 289 kr

Beställningsvara. Skickas inom 5-8 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This second volume chronicles the later stages of the outbreak of SARS-Cov-2 (COVID-19) and delineates the role of several disciplines in therapeutic and control measures highliting the response from specific coutries of note and efforts to repurpose and produce new therapeutics and vaccines. By addressing considerations of efficacy and safety of drugs and chemicals used to combat COVID-19, virtually in real-time, this book documents and highlights the advances in science and place the toxicology, pharmaceutical science, public health and medical community in a better position to advise in future epidemics.

Produktinformation

Utgivningsdatum2022-04-27
Mått156 x 234 x 43 mm
Vikt1 203 g
FormatInbunden
SpråkEngelska
Antal sidor694
FörlagRoyal Society of Chemistry
ISBN9781839166785

Tillhör följande kategorier

Samhällsmedicin och preventiv medicin inom Medicin
Biokemi inom Naturvetenskap och teknik
Organisk kemi inom Naturvetenskap och teknik
Patologi inom Medicin

Michael D. Waters, holds a Ph.D. in Biochemistry from the University of North Carolina School of Medicine at Chapel Hill and a B.S. in Pre-medicine (Chemistry and Biology) from Davidson College. He is a former government scientist with more than 35 years of experience in research and research management positions at EPA and NIH/NIEHS and six years of private sector experience as Chief Scientific Officer at Integrated Laboratory Systems, Inc. His research interests have centered on the evaluation of chemically-induced mutations and altered molecular expression in the etiology of genetic disease. He is a widely-published scientist having published well over 100 peer-reviewed in authoritative international scientific journals. He has edited Mutation Research-Reviews for nearly 20 years and has held adjunct professorships at both the University of North Carolina and at Duke University for many years. He served as President of both the Environmental Mutagen Society and the International Association of Environmental Mutagen Societies (now the Environmental Mutagenesis and Genomics Society and the International Association of Environmental Mutagenesis and Genomics Societies, with more than seven thousand members worldwide). The databases he has developed and a number of his publications are recognized as important advances that have significantly impacted the fields of genetic toxicology, carcinogenesis, toxicogenomics, and risk assessment.

In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection;Vaccination and Vaccines for COVID-19;Understanding Emergence of SARS-CoV-2 Viral Variants from a Genomic Perspective;Susceptibility and Spread of SARS-Cov-2 in Animals;Profiling Some Plant-based Immunomodulatory Bioactive Compounds for COVID-19 Prophylaxis and Treatment Based on Indian Traditional Medicine;The Potential Therapeutic effects of Natural Products, Herbs, Mushrooms Against COVID-19;Application of Chinese Herbal Medicine in COVID-19;COVID-19 Interventional and Therapeutic Clinical Trials: Small Molecules, Interactions, Outcomes and Opportunities;A Trend Analysis of COVID-19 Pandemic in Turkey;The Swedish Approach to COVID-19;New Zealand’s Response to the First Wave of COVID-19;Significant SARS-CoV-2 Variants Circulating Around the World: Origin, Spread and Phylodynamics;Survival of SARS-CoV-2 Outside the Body and Methods of Disinfection;U.S. Regulatory Approaches to Disinfectants for Coronavirus;Diagnostic Strategies for Early and Point-of-care Detection of COVID-19 in Clinical and Personalized Settings;Human Resource Management, Preparedness and Outcomes;Role of Telehealth during the COVID-19 Pandemic;Medical Education During the Covid Pandemic: Challenges and Solutions;Containment Strategies to Prevent Spread in Different Societies and Cultures;Effective Health Education, Patient Education, Health Behaviour Change;Strengthening the Biological and Toxin Weapons Convention after COVID-19: Reaching Agreement on a Code of Conduct and Biological Security Education at the 2021 9th Review Conference;COVID-19 Prevention;Human Response to Pandemics in History and Medico-anthropological Correlates;The COVID-19 Pandemic - Global Lessons for the Future